Lv21
160 积分 2025-10-28 加入
The Value of Different Systemic Inflammatory Response Indicators in the Long-term Prognosis of Type B Aortic Dissection Patients Undergoing Thoracic Endovascular Aortic Repair
5小时前
已完结
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
1个月前
已完结
[Guidelines for the diagnosis and treatment of acute pulmonary embolism 2025]
1个月前
已完结
Asundexian for Secondary Stroke Prevention
2个月前
已完结
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2个月前
已完结
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
2个月前
已完结
Development and in vitro-in vivo evaluation of a novel sustained-release tablet based on constant-release surface
2个月前
已完结
A Novel Imaging Technique to Investigate the Influence of Atomization Air Pressure on Film–Tablet Interfacial Thickness
2个月前
已完结
Association of Lipoprotein(a) With Severe Degenerative Aortic Valve Stenosis
3个月前
已完结
Multiomics Analysis Reveals Stromal Cell State Changes and INHBA-Associated Remodeling in Calcific Aortic Valve Disease
3个月前
已完结
皖公网安备34019202002308
